Venkata P. Garikapaty, Ph.D.
Affiliations: | 2004 | New York Medical College, New York, NY, United States |
Area:
Microbiology Biology, Public Health, Oncology, NutritionGoogle:
"Venkata Garikapaty"Cross-listing: PHTree
Parents
Sign in to add mentor| Raj K. Tiwari | grad student | 2004 | New York Medical College | |
| (Cellular and molecular targets of 3,3'-diindolylmethane: A second generation anti-prostate cancer agent from cruciferous vegetables.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| DiPaola RS, Dvorzhinski D, Thalasila A, et al. (2008) Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. The Prostate. 68: 1743-52 |
| Ashok BT, Tadi K, Garikapaty VP, et al. (2007) Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents. Anti-Cancer Drugs. 18: 87-94 |
| Garikapaty VP, Ashok BT, Tadi K, et al. (2006) 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochemical and Biophysical Research Communications. 340: 718-25 |
| Garikapaty VP, Ashok BT, Tadi K, et al. (2006) Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. The Prostate. 66: 453-62 |
| Dipaola RS, Dvorzhinski D, Nelson D, et al. (2005) 2-deoxyglucose (2DG) bypasses Bcl-2 and Akt mediated resistance in prostate cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9535 |
| Stein MN, Todd MB, Morton RA, et al. (2005) A completed phase I trial of 13-cis retinoic acid, alpha interferon, docetaxel, and estramustine (R.I.T.E.) for the treatment of hormone refractory prostate cancer (HRPC) and other advanced malignancies and effect on BCL-2 expression. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4740 |
| Garikapaty VP, Ashok BT, Chen YG, et al. (2005) Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncology Reports. 13: 89-93 |
| Chen YG, Ashok BT, Liu X, et al. (2003) Induction of heat shock protein gp96 by immune cytokines. Cell Stress & Chaperones. 8: 242-8 |
| Ashok BT, David L, Chen YG, et al. (2003) Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. International Journal of Molecular Medicine. 11: 465-71 |
| Ashok BT, Chen YG, Liu X, et al. (2002) Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 11: S86-93 |